C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof

Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
11/2011
11/29/2011	US8066982 Irreversibly-inactivated pepsinogen fragment and pharmaceutical compositions comprising the same for detecting, preventing and treating HIV
11/29/2011	CA2440461C Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer
11/24/2011	WO2011145639A1 Crystal of oxidized alanylcysteine and method for producing same
11/24/2011	WO2011144924A1 Amine or amid analogues of sanglifehrin
11/24/2011	WO2011144892A1 Cationic lipids
11/24/2011	WO2011144714A1 Kissorphin peptides for use in the treatment of alzheimer's disease, creutzfeldt- jakob disease or diabetes mellitus
11/24/2011	US20110288271 Agent derived from tortoise spleen stimulating mammalian hemopoiesis
11/24/2011	US20110287406 Novel HCV core+1 protein, methods for diagnosis of HCV infections, prophylaxis, and for screening of anti-HCV agents
11/24/2011	US20110286969 Deuterated compounds as hepatitis c virus (hcv) inhibitors
11/23/2011	EP2388254A1 Bioluminescent protease assay
11/23/2011	EP2388012A1 Kisspeptin peptides for use in the treatment of Alzheimer's disease, Creutzfeldt-Jakob disease or diabetes mellitus
11/23/2011	EP1509541B1 Novel recombinant anticoagulant proteins
11/23/2011	CN102250205A Preparation method of fatty acyl-RGD (Arg Gly Asp) induced docetaxel target liposome and antitumor activity thereof
11/23/2011	CN102250204A RGD sequence peptidyl methyl curcumin compounds, preparation method thereof, and application thereof
11/23/2011	CN102250203A Beta-carboline aminoacid benzyl ester, preparation method and application thereof
11/23/2011	CN102250202A 1-paranitrophenyl-beta-carboline-3-formyl amine acid carbamates and synthesis method and use thereof
11/23/2011	CN102250127A Tetrahydro carboline derivative modified with two amino acids and preparation method and application thereof
11/23/2011	CN102249851A Process for the preparation of 3,3-dimethylbutanal
11/23/2011	CN101497655B Polypeptide hydration salt compound and use for anti-depression aspect
11/22/2011	US8063269 Fatty acid desaturase for controlling fatty acid concentration in seeds of crop plants
11/22/2011	US8063263 Methods for the treatment or prevention of scars and/or keloids
11/22/2011	US8063202 Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides
11/22/2011	US8063183 Ephrin extracellular domain polypeptides for use in diagnosis prevention and treatment of cell proliferative disorders
11/22/2011	US8063056 Anti-cancer cyclopenta [g]quinazonline compounds
11/22/2011	CA2547873C Tetrapeptide regulating blood glucose level in diabetes mellitus
11/16/2011	EP2386565A2 Compounds and methods to inhibit or augment an inflammatory response
11/16/2011	EP2103630B1 Preparation of low bleeding anticoagulant fusion protein and its use
11/16/2011	EP2027152B1 Peptide fragments for inducing synthesis of extracellular matrix proteins
11/16/2011	EP1664089B1 Base-substituted benzylamine analogs for use as coagulation factor xa inhibitors, the production and use thereof
11/16/2011	EP1605963B1 Inhibitors of antigen presentation by mhc class ii molecules and methods of use thereof
11/16/2011	CN1930182B Antithrombotic compound
11/16/2011	CN102241743A Process for producing sugar peptide having asparagine sugar chain and the sugar peptide
11/16/2011	CN102241741A Prion protein ligands and methods of use
11/16/2011	CN102241740A Compounds with thrombolytic activities and preparation methods and applications thereof
11/16/2011	CN102241737A Endomorphin-1 analogs, synthesis thereof and application of endomorphin-1 analogs in preparation of analgesic medicines
11/16/2011	CN102241736A Method for synthesizing key intermediate of antitumour medicament Romidepsi
11/16/2011	CN102241735A Polypeptide used for prevention and treatment of acute coronary syndrome and anticoagulation antithrombotic therapy and application thereof
11/16/2011	CN102241675A (1R,3S)-1-(4-hydroxyl-3-methoxycarboxyl)-1,2,3,4-tetrahydro-beta-carboline-3-formyl amino acid derivatives as well as preparation method and application thereof
11/16/2011	CN102241674A Synthesis method and antitumor activity evaluation of 1,1-dimethyl-beta-carboline-3-formacyl amino acid benzyl ester
11/16/2011	CN101302245B Melanin cortical hormone receptor tetrapeptide excitant, preparation and use thereof
11/15/2011	US8058410 comprising solid phase and an affinity ligand comprising peptide bonds coupled to this solid phase; capturing and purifying Npro, Npro-mutants, Nprofusion proteins expressed as inclusion bodies under denaturing conditions or proteins with a high aggregation tendency using peptide affinity chromatography
11/15/2011	US8058393 Microwave-assisted peptide synthesis
11/15/2011	US8058256 Polymeric carrier for delivery of small interfering RNA
11/15/2011	US8058244 Cyclic peptide antitumor agents
11/15/2011	US8058238 High purity lipopeptides
11/15/2011	US8057810 Peptide substance revealing an immunogeroprotective effect, pharmaceutical composition on its base and the method of its application
11/15/2011	CA2418793C Pharmaceutical composition comprising an analgesic peptide
11/10/2011	WO2011139992A1 Aromatic-cationic peptides and uses of same
11/10/2011	US20110275784 Asymmetric synthesis of peptides
11/10/2011	US20110275562 Inhibition of gliadin peptides
11/10/2011	US20110275555 Compositions containing delta-9-thc-amino acid esters and process of preparation
11/10/2011	US20110275146 Fusion proteins comprising dp-178 and other viral fusion inhibitor peptides useful for treating aids
11/09/2011	EP2384334A1 A method of producing a novel opioid peptide
11/09/2011	EP1879910B1 Tripeptides as hepatitis c virus inhibitors
11/09/2011	EP1551864B1 Substrates for detection of TAFI(a)
11/09/2011	CN1845920B 2-amido-4-aryloxy-1-carbonylpyrrolidine derivatives as inhibitors of serine proteases, particularly HCV NS3-NS4A protease
11/09/2011	CN102234314A Method for preparing a group of snake venom derived active peptides and application of active peptides in anti-tumor aspect
11/09/2011	CN102234313A Method for synthesizing pidotimod
11/09/2011	CN102234309A Preparation method of peptide with a C-terminal of fluoride methyl ketone
11/09/2011	CN101597290B Beta-carboline-3-formyl tryptophyl amine acid carbamate as well as preparation method and application thereof
11/09/2011	CN101591375B Compound with analgesic activity, preparation method and application thereof
11/09/2011	CN101200493B (3S)-N-(L-aminoacyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, preparation method and uses thereof
11/08/2011	US8053556 Glypican-3 (GPC3)-derived tumor rejection antigenic peptides useful for HLA-A2-positive patients and pharmaceutical comprising the same
11/08/2011	US8053554 Peptide nanostructures and methods of generating and using the same
11/08/2011	US8053551 Comprises six transmembrane epithelial antigen of the prostate-2 protein (STEAP)) for diagnosis and treatment of cell proliferative and tumor disorders; genetic vaccine; antitumor agents
11/08/2011	US8053209 FRET protease assays for clostridial toxins
11/08/2011	US8053208 FRET protease assays for clostridial toxins
11/08/2011	US8053194 Labeling substance and chimeric substance and method for preparing the same and method for capturing, structurally analyzing and/or identifying biological substance by means of the labeling substance
11/08/2011	US8052975 Compounds and methods for treatment and diagnosis of chlamydial infection
11/08/2011	CA2343414C Fc receptor modulators and uses thereof
11/03/2011	WO2011136905A2 Crystalline peptide epoxyketone immunoproteasome inhibitor
11/03/2011	WO2011135905A1 Lipid membrane structure
11/03/2011	WO2011066285A3 Peptide-based treatment for neurodegenerative diseases
11/03/2011	WO2011048390A3 Gadd45beta targeting agents
11/03/2011	WO2011047097A3 Inhibition of trem receptor signaling with peptide variants
11/03/2011	US20110269943 Radiolabeled annexins
11/03/2011	US20110269938 Amyloid-beta peptide crystal structure
11/03/2011	US20110269697 Organoarsenic compounds and methods for the treatment of cancer
11/03/2011	US20110269696 Inhibitors of iaps
11/03/2011	US20110269695 Novel anti-aging peptides and cosmetic and/or pharmaceutical composition containing same
11/03/2011	US20110269694 Novel anti-aging peptides and cosmetic and/or pharmaceutical composition containing same
11/03/2011	US20110269679 Inhibitors of amyloid fibril formation and uses thereof
11/03/2011	US20110266517 Peptide nanostructures encapsulating a foreign material and method of manufacturing same
11/03/2011	CA2795559A1 Crystalline peptide epoxyketone immunoproteasome inhibitor
11/02/2011	EP2383281A2 Prion-specific peptoid reagents
11/02/2011	EP2382996A2 Lipid Film Structure Containing a Polyoxyalkylene Chain-Containing Lipid Derivative.
11/02/2011	EP2382232A1 Process for the production of bivalirudin
11/02/2011	EP2382231A2 New compounds, in particular peptides, compositions comprising them and cosmetic and dermopharmaceutical uses
11/02/2011	EP2382230A2 Kxk-peptide compositions for cosmetic and dermo-pharmaceutic uses
11/02/2011	EP2382229A2 CYSTEINE-FREE TECHNETIUM (Tc) OR RHENIUM (Re) CHELATING PEPTIDE TAGS AND THEIR USE
11/02/2011	EP2382184A2 Mass- and property-tuned variable mass labeling reagents and analytical methods for simultaneous peptide sequencing and multiplexed protein quantification using thereof
11/02/2011	EP1730110B9 Sulfur compounds as inhibitors of hepatitis c virus ns3 serine protease
11/02/2011	CN1437504B Dispersants
11/02/2011	CN102229650A High purity lipopeptides, lipopeptide micelles and processes for preparing same
11/01/2011	USRE42889 α- and β- amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/01/2011	US8048984 Human GIL-19/AE289 proteins
11/01/2011	US8048983 HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells
11/01/2011	US8048911 Melanin eliminator preparation
11/01/2011	US8048852 Antimicrobial compounds and formulations
11/01/2011	CA2458813C Anti-cancer cyclopenta[g]quinazoline compounds

1 ... 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 ... 307